COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(0.0%)
USD 46.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 51.42 Billion JPY | 13.15% |
| 2023 | 47.49 Billion JPY | 5.16% |
| 2022 | 44.9 Billion JPY | -3.43% |
| 2021 | 46.93 Billion JPY | 9.86% |
| 2020 | 42.65 Billion JPY | 12.25% |
| 2019 | 37.73 Billion JPY | 8.33% |
| 2018 | 34.63 Billion JPY | 5.16% |
| 2017 | 32.94 Billion JPY | 16.57% |
| 2016 | 28.23 Billion JPY | 14.93% |
| 2015 | 24.42 Billion JPY | 10.81% |
| 2014 | 22.31 Billion JPY | 13.07% |
| 2013 | 20.95 Billion JPY | 19.15% |
| 2012 | 17.58 Billion JPY | 30.65% |
| 2011 | 13.04 Billion JPY | 25.47% |
| 2010 | 10.75 Billion JPY | 38.97% |
| 2009 | 6.87 Billion JPY | 17.55% |
| 2008 | 6.61 Billion JPY | 24.22% |
| 2007 | 5.26 Billion JPY | 16.64% |
| 2006 | 4.44 Billion JPY | 52.07% |
| 2005 | 2.93 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - JPY | 1.83% |
| 2024 Q4 | 13.18 Billion JPY | -39.8% |
| 2024 Q3 | 12.99 Billion JPY | 71.11% |
| 2024 Q1 | 9.71 Billion JPY | 8.36% |
| 2024 Q2 | 7.66 Billion JPY | -43.04% |
| 2023 FY | - JPY | 5.16% |
| 2023 Q2 | 7.28 Billion JPY | -24.41% |
| 2023 Q3 | 7.5 Billion JPY | 3.03% |
| 2023 Q4 | 8.71 Billion JPY | 16.06% |
| 2023 Q1 | 9.63 Billion JPY | 9.84% |
| 2022 Q3 | 7.62 Billion JPY | 5.72% |
| 2022 FY | - JPY | -3.43% |
| 2022 Q4 | 8.77 Billion JPY | 15.13% |
| 2022 Q2 | 7.2 Billion JPY | -22.59% |
| 2022 Q1 | 9.31 Billion JPY | 16.53% |
| 2021 Q1 | 11.27 Billion JPY | 7.9% |
| 2021 Q2 | 8.34 Billion JPY | -26.0% |
| 2021 Q4 | 7.99 Billion JPY | -4.06% |
| 2021 Q3 | 8.32 Billion JPY | -0.2% |
| 2021 FY | - JPY | 9.86% |
| 2020 Q1 | 7.54 Billion JPY | -1.05% |
| 2020 Q4 | 10.45 Billion JPY | 28.94% |
| 2020 FY | - JPY | 12.25% |
| 2020 Q3 | 8.1 Billion JPY | 44.85% |
| 2020 Q2 | 5.59 Billion JPY | -25.84% |
| 2019 FY | - JPY | 8.33% |
| 2019 Q3 | 6.2 Billion JPY | 4.06% |
| 2019 Q4 | 7.62 Billion JPY | 22.88% |
| 2019 Q1 | 7.57 Billion JPY | -0.73% |
| 2019 Q2 | 5.96 Billion JPY | -21.2% |
| 2018 Q2 | 4.75 Billion JPY | -30.91% |
| 2018 FY | - JPY | 5.16% |
| 2018 Q4 | 7.62 Billion JPY | 25.37% |
| 2018 Q3 | 6.08 Billion JPY | 27.98% |
| 2018 Q1 | 6.87 Billion JPY | 24.94% |
| 2017 Q1 | 7.31 Billion JPY | 26.42% |
| 2017 Q4 | 5.5 Billion JPY | -9.62% |
| 2017 FY | - JPY | 16.57% |
| 2017 Q2 | 5.78 Billion JPY | -20.94% |
| 2017 Q3 | 6.09 Billion JPY | 5.4% |
| 2016 Q2 | 4.68 Billion JPY | -15.13% |
| 2016 FY | - JPY | 14.93% |
| 2016 Q3 | 4.78 Billion JPY | 2.07% |
| 2016 Q1 | 5.52 Billion JPY | 1.96% |
| 2016 Q4 | 5.78 Billion JPY | 20.86% |
| 2015 FY | - JPY | 10.81% |
| 2015 Q1 | 4.72 Billion JPY | 25.85% |
| 2015 Q2 | 4.71 Billion JPY | -0.21% |
| 2015 Q3 | 4.22 Billion JPY | -10.54% |
| 2015 Q4 | 5.41 Billion JPY | 28.39% |
| 2014 Q1 | 5.53 Billion JPY | 31.54% |
| 2014 FY | - JPY | 13.07% |
| 2014 Q4 | 3.75 Billion JPY | -13.56% |
| 2014 Q3 | 4.34 Billion JPY | -5.61% |
| 2014 Q2 | 4.6 Billion JPY | -16.88% |
| 2013 Q4 | 4.21 Billion JPY | 16.17% |
| 2013 FY | - JPY | 19.15% |
| 2013 Q1 | 5.23 Billion JPY | 37.84% |
| 2013 Q2 | 3.77 Billion JPY | -27.91% |
| 2013 Q3 | 3.62 Billion JPY | -3.97% |
| 2012 Q1 | 4.13 Billion JPY | 7.42% |
| 2012 FY | - JPY | 30.65% |
| 2012 Q3 | 3.38 Billion JPY | 3.39% |
| 2012 Q2 | 3.27 Billion JPY | -20.86% |
| 2012 Q4 | 3.79 Billion JPY | 12.17% |
| 2011 FY | - JPY | 25.47% |
| 2011 Q4 | 3.85 Billion JPY | 23.38% |
| 2011 Q1 | 3.68 Billion JPY | 10.37% |
| 2011 Q2 | 2.88 Billion JPY | -21.63% |
| 2011 Q3 | 3.12 Billion JPY | 8.14% |
| 2010 Q2 | 2.89 Billion JPY | -0.58% |
| 2010 Q1 | 2.91 Billion JPY | 7.14% |
| 2010 Q4 | 3.33 Billion JPY | 52.63% |
| 2010 FY | - JPY | 38.97% |
| 2010 Q3 | 2.18 Billion JPY | -24.46% |
| 2009 Q2 | 1.33 Billion JPY | 0.0% |
| 2009 Q4 | 2.71 Billion JPY | 66.95% |
| 2009 FY | - JPY | 17.55% |
| 2009 Q3 | 1.62 Billion JPY | 22.13% |
| 2008 FY | - JPY | 24.22% |
| 2007 FY | - JPY | 16.64% |
| 2006 FY | - JPY | 52.07% |
| 2005 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | 20479471248.102% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | 21269233.576% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | -57422.818% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | 3633686.19% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -47.95 Thousand USD | 107231427.411% |
| HealthWarehouse.com, Inc. | -1.27 Million USD | 4032540.816% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | -108779.573% |
| MedGen, Inc. | -15.37 USD | 334586857614.639% |
| Omni Health, Inc. | 1.28 Million USD | -3993848.422% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | 14950996.31% |
| Pineapple, Inc. | -1.47 Million USD | 3485951.48% |
| ScripsAmerica, Inc. | -3.95 Million USD | 1300553.057% |